Loading...
HSChapter 30
U.S. imports of heparin and its salts; other human or animal substances (HS 300190) totaled $18.3M in April 2026, traded with 41 countries.
Importers of Heparin and Its Salts; Other Human or Animal Substances paid $30K in duties in April 2026 — an effective duty rate of 10% on $302K in dutiable value, based on actual customs collections rather than the published tariff schedule. Heparin and Its Salts; Other Human or Animal Substances imports of $18.3M in April 2026 ran 17% below the year-to-date monthly average of $22.0M.
Last updated: April 2026 dataHeparin, an anticoagulant derived primarily from porcine intestinal mucosa, is one of the most clinically critical biological drug substances in global trade, and its supply chain drew intense regulatory scrutiny following the 2008 adulteration crisis. The US schedule subdivides the heading into dried liver and glands (3001900110, 3001900115, 3001900150), heparin and its salts (3001900165 and 3001900190), and other human or animal substances (3001900195). India and China are the leading suppliers, with Germany also a significant source; the concentration of porcine mucosa processing in China and India makes supply-chain traceability and FDA facility oversight a persistent compliance priority. Importers should consult a licensed customs broker and confirm FDA registration and cGMP status of the foreign establishment prior to entry.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
FDA expects importers to maintain full traceability from the crude heparin source (typically porcine intestinal mucosa) through each processing step to the finished API. Required documentation typically includes certificates of analysis, supplier audit records, and evidence of FDA facility registration for each manufacturing site in the supply chain, consistent with FDA's heparin guidance issued after the 2008 adulteration incident.
The heading's 10-digit lines separate dried or powdered glandular material (3001900110, 3001900115, 3001900150) from heparin and its salts as discrete chemical entities (3001900165, 3001900190). The key distinction is whether the imported material is a processed, characterized drug substance (heparin) or a less-refined dried biological tissue; importers should ensure the certificate of analysis and product description clearly support the claimed line.
Supplier Network
Get discovered by U.S. importers searching for HS 300190 — Heparin and Its Salts; Other Human or Animal Substances. Be the first supplier listed.
Monthly import values over time
| Country | Imports | Exports | Balance |
|---|---|---|---|
| CHINA | $8.4M | $1.6M | -$6.8M |
| SWEDEN | -- | $7.7M | +$7.7M |
| INDIA | $4.3M | $947K | -$3.4M |
| KOREA, SOUTH | $67K | $5.1M | +$5.1M |
| CANADA | $409K | $4.3M | +$3.9M |
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Duty Collected |
|---|---|---|---|---|
| 3001900195 | OTHER HUMAN OR ANIMAL SUBSTANCE, NESOI | $14.8M | -- | -- |
| 3001900110 | LIVER, DRIED, WHETHER OR NOT POWDERED | $1.2M | 10.00% | $26K |
| 3001900150 | OTHER GLANDS AND ORGANS, DRIED ETC | $1.1M | 10.00% | $4K |
| 3001900165 | HEPARIN AND ITS SALTS | $1.1M | -- | -- |
| 3001900190 | HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBST | $0 | -- | -- |
OTHER HUMAN OR ANIMAL SUBSTANCE, NESOI
LIVER, DRIED, WHETHER OR NOT POWDERED
OTHER GLANDS AND ORGANS, DRIED ETC
HEPARIN AND ITS SALTS
HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBST
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3001900190 | HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBST | $40.1M |
| 3001900115 | GLANDS AND OTHER ORGANS, DRIED, INCL POWDERED | $1.7M |
HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBST
61.8K kg
GLANDS AND OTHER ORGANS, DRIED, INCL POWDERED
10.3K kg
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| Ohio | -- | $11.2M | +$11.2M |
| California | $9.2M | $1.1M | -$8.1M |
| Georgia | $4.3M | $1.6M | -$2.7M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| CHICAGO, IL | $427K | $12.0M | +$11.6M |
| NEW ORLEANS, LA | $666K | $5.4M | +$4.7M |
| CLEVELAND, OH | $72K | $5.6M | +$5.6M |